| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.21 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |